Technical Analysis for AURA - Aura Biosciences, Inc.

Grade Last Price % Change Price Change
D 15.7 -5.19% -0.86
AURA closed down 5.19 percent on Tuesday, December 7, 2021, on 1.26 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Down
Historical AURA trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New Downtrend Bearish -5.19%
Hot IPO Pullback Bullish Swing Setup -5.19%
Stochastic Reached Oversold Weakness -5.19%
Outside Day Range Expansion -5.19%
Wide Bands Range Expansion -5.19%
Oversold Stochastic Weakness -5.19%
Older End-of-Day Signals for AURA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 15 hours ago
Down 5% about 15 hours ago
Down 3% about 15 hours ago
Fell Below Previous Day's Low about 15 hours ago
Down 2 % about 15 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Melanoma Tumors Neoplasms Rare Disease Uveal Melanoma

Is AURA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.16
52 Week Low 14.0
Average Volume 164,749
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 19.47
10-Day Moving Average 18.71
Average True Range 3.04
ADX 25.46
+DI 15.50
-DI 18.06
Chandelier Exit (Long, 3 ATRs) 17.05
Chandelier Exit (Short, 3 ATRs) 24.11
Upper Bollinger Bands 24.74
Lower Bollinger Band 14.20
Percent B (%b) 0.14
BandWidth 54.10
MACD Line -0.15
MACD Signal Line 0.48
MACD Histogram -0.6288
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.65
Resistance 3 (R3) 19.85 18.74 18.99
Resistance 2 (R2) 18.74 17.74 18.64 18.77
Resistance 1 (R1) 17.22 17.11 16.67 17.02 18.55
Pivot Point 16.11 16.11 15.83 16.01 16.11
Support 1 (S1) 14.59 15.11 14.04 14.39 12.85
Support 2 (S2) 13.48 14.48 13.38 12.63
Support 3 (S3) 11.96 13.48 12.41
Support 4 (S4) 11.76